Medina L. Woodson

Medina L. Woodson serves as a key procurement lead within the W40M MRC0 West agency under the Department of the Army, responsible for acquiring advanced in-vitro diagnostic substances and associated medical technologies critical to military medical readiness. Their role centers on ensuring operational sovereignty by securing high-acuity diagnostic, laboratory, and blood management systems that support field-deployable care environments. Woodson manages the full lifecycle of complex solicitations, from requirements validation through contract award and performance monitoring, with a singular focus on mission-critical medical diagnostics that enable rapid, accurate clinical decision-making in austere settings. Woodson maintains strategic relationships with industry leaders including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These partnerships reflect a preference for established, FDA-registered manufacturers and system integrators capable of delivering validated, sterile, and deployable diagnostic platforms. The working relationship is characterized by rigorous technical compliance, adherence to military specifications, and consistent performance expectations under expeditionary conditions, with an emphasis on supply chain resilience and regulatory certification. Woodson’s contracting portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a mission-driven prioritization of technical capability, regulatory compliance, and operational readiness over socioeconomic classifications, indicating a deliberate focus on performance outcomes rather than socioeconomic criteria in high-stakes medical procurement contexts. The agency’s procurement activity is exclusively aligned with NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—indicating deep specialization in molecular diagnostics, immunoassay systems, point-of-care testing platforms, and associated reagents and consumables. Woodson’s expertise lies in procuring clinically validated, ruggedized diagnostic solutions that meet DoD standards for stability, accuracy, and field usability, ensuring military medical units maintain diagnostic autonomy across the full spectrum of operations.